EDNAH OYARO: Open Payments
NPI 1932675345 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,477 in 64 payments from 17 companies in 2025. Trend: 2023 $1,413 · 2024 $1,689 · 2025 $1,477
Food & beverage: $1,477
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $426 |
| Regeneron Healthcare Solutions, Inc. | 14 | $246 |
| GENZYME CORPORATION | 10 | $230 |
| GlaxoSmithKline, LLC. | 12 | $186 |
| Galderma Laboratories, L.P. | 3 | $54 |
| PFIZER INC. | 2 | $51 |
| CSL Behring | 2 | $47 |
| Lilly USA, LLC | 2 | $41 |
| AYTU BioPharma, Inc. | 2 | $37 |
| Paratek Pharmaceuticals, Inc. | 1 | $26 |
Products named: DUPIXENT, FASENRA, TEZSPIRE, NUCALA, NEMLUVIO, PANZYGA, EBGLYSS, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
